IPC’s International Fellowship program offers early-career dermatologists and researchers interested in psoriasis the opportunity to learn directly from our global network of experts, demonstrating our commitment to developing the next generation of leaders in the field.
IPC offers two fellowship tracks: Clinical and Research. Both are 12-month programs that include virtual mentoring, skills development classes, and co-mentoring groups based on special interest topics. Clinical fellows will participate in up to four weeks of on-site clinical experience, while research fellows will spend up to twelve weeks on-site with a research mentor. Applicants may apply to one or both tracks through a single application.
The project is led by the Fellowship Program Advisory Committee.
Awarded fellows are matched with IPC Board Members or Councilors to observe and participate in clinical practice or research involving patients with psoriasis. Fellows gain hands-on experience in real-world settings, whether through investigating, diagnosing, and managing psoriasis in clinical practice, or participating in active research projects in the lab or clinic. In addition, the program fosters lasting professional relationships by engaging fellows in IPC activities and connecting them with global leaders in the field throughout the fellowship year.
The 2026 IPC International Fellowship Program is supported in part by: Johnson & Johnson
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
